These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Chemotherapy of malignant brain tumors--scientific basis for combination chemotherapy]. Arita N; Hayakawa T Gan To Kagaku Ryoho; 1991 Feb; 18(2):180-7. PubMed ID: 1992911 [TBL] [Abstract][Full Text] [Related]
9. Predictive biomarkers in adult gliomas: the present and the future. Thomas L; Di Stefano AL; Ducray F Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583 [TBL] [Abstract][Full Text] [Related]
10. [HIT-GBM: multicenter study of treatment of children with malignant glioma]. Wolff JE; Boos J; Kühl J Klin Padiatr; 1996; 208(4):193-6. PubMed ID: 8926684 [TBL] [Abstract][Full Text] [Related]
12. Grade II gliomas-not so low grade. Shonka NA Oncology (Williston Park); 2014 Dec; 28(12):1016. PubMed ID: 25510801 [No Abstract] [Full Text] [Related]
13. Treatment of malignant brain tumors. Takakura K; Kubo O Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():449-53. PubMed ID: 10895194 [No Abstract] [Full Text] [Related]
14. Locoregional approaches to therapy with gliomas as the paradigm. Liang BC; Weil M Curr Opin Oncol; 1998 May; 10(3):201-6. PubMed ID: 9619355 [TBL] [Abstract][Full Text] [Related]
15. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas. Cheng YS; Lin C; Cheng YP; Yu YL; Tang CT; Hueng DY Neurol India; 2014; 62(4):406-9. PubMed ID: 25237947 [TBL] [Abstract][Full Text] [Related]